Zura Bio Ltd
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
ZURA$1.41+13.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except share data)
| | | | | | | |
|---|---|---|---|---|---|---|
| · September 30, · December 31, | ||||||
| · · 2024 · · 2023 | ||||||
| · · (unaudited) · · · | ||||||
| Assets | | | | | | |
| Current assets: · · · · | ||||||
| Cash and cash equivalents | | $188,221 | | $99,806 | ||
| Prepaid expenses and other current assets | | | 754 | | | 1,037 |
| Total current assets | | | 188,975 | | | 100,843 |
| Property and equipment, net | | | 44 | | | — |
| Other assets | | | 52 | | | — |
| Total assets | | $189,071 | | $100,843 | ||
| | | | | | | |
| Liabilities, Redeemable Noncontrolling Interest and Shareholders’ Equity | | | | | | |
| Current liabilities: | | | | | | |
| Accounts payable and accrued expenses | | $18,244 | | $20,302 | ||
| Total current liabilities | | | 18,244 | | | 20,302 |
| Private placement warrants | | | — | | | 990 |
| Total liabilities | | | 18,244 | | | 21,292 |
| | | | | | | |
| Commitments and contingencies (Note 9) | | | | | | |
| | | | | | | |
| Redeemable noncontrolling interest | | | 16,240 | | | 18,680 |
| | | | | | | |
| Shareholders’ Equity: | | | | | | |
| Preferred shares, $0.0001 par value, 1,000,000 authorized as of September 30, 2024, and December 31, 2023; -0- issued and outstanding as of September 30, 2024, and December 31, 2023 | | | — | | | — |
| Class A Ordinary Shares, $0.0001 par value, 300,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 65,293,530 and 43,593,678 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | | | 7 | | | 4 |
| Additional paid-in capital | | | 295,311 | | | 162,820 |
| Accumulated deficit | | | (142,272) | | | (103,494) |
| Total Zura Bio Limited shareholders’ equity | | | 153,046 | | | 59,330 |
| Noncontrolling interest | | | 1,541 | | | 1,541 |
| Total shareholders’ equity | | | 154,587 | | | 60,871 |
| Total liabilities, redeemable noncontrolling interest and shareholders’ equity | | $189,071 | | $100,843 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.